Central neurochemical ultradian variability in depression

Disease Markers

Volumn 22, Issue 1-2, 2006, Pages 65-72

  Salomon, Ronald M ^a,b   Johnson, Benjamin W ^a   Schmidt, Dennis E ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VAV Psychiatry 2200   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; SEROTONIN; SERTRALINE; TRYPTOPHAN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BRAIN FUNCTION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DATA ANALYSIS; DEPRESSION; DISEASE MARKER; FEMALE; FREQUENCY ANALYSIS; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MONOAMINE METABOLISM; NEUROCHEMISTRY; NEUROENDOCRINE SYSTEM; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SAMPLING; SEROTONIN METABOLISM; ULTRADIAN RHYTHM;

EID: 29244483452     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/240980     Document Type: Article

References (21)

1. M. Akay, Y.M. Akay, P. Cheng and H.H. Szeto, Investigating the effects of opioid drugs on electrocortical activity using wavelet transform, Biol Cybern 72 (1995), 431-437.
2. D. Akin, D.H. Manier, E. Sanders-Bush and R.C. Shelton, Decreased Serotonin 5-HT(2A) Receptor-Stimulated Phosphoinositide Signaling in Fibroblasts from Melancholic Depressed Patients, Neuropsychopharmacology 29 (2004), 2081-2087.
3. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, (Fourth ed.), Washington, DC, APA, 1994.
4. R. Armitage, R. Hoffmann, G. Emslie, J. Rintelman, J. Moore and K. Lewis, Rest-activity cycles in childhood and adolescent depression, J Am Acad Child Adolesc Psychiatry 43 (2004), 761-769.
5. O. Benoit, S. Royant-Parola, A.A. Borbely, I. Tobler and D. Widlocher, Circadian aspects of motor activity in depressed patients, Acta Psychiatr Belg 85 (1985), 582-592.
6. D.B. Boivin, C.A. Czeisler, D.J. Dijk, J.F. Duffy, S. Folkard, D.S. Minors, P. Totterdell and J.M. Waterhouse, Complex interaction of the sleep-wake cycle and circadian phase modulates mood in healthy subjects, Arch Gen Psychiatry 54 (1997), 145-152.
7. M. Candito, D. Pringuey, A. Iordache, E. Souetre, P. Chambon and G. Darcourt, Circadian variation in total plasma tryptophan. Antidepressant treatment: drugs and phase advance, Life Sci 50 (1992), PL71-74.
8. I. Daubechies, Ten Lectures on Wavelets, SIAM, Philadelphia, PA, 1990.
9. G. Engstrom, C. Alling, K. Blennow, G. Regnell and L. Traskman-Bendz, Reduced cerebrospinal HVA concentrations and HVA:5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls, Eur Neuropsychopharmacol 9 (1999), 399-405.
10. M.B. First, R.L. Spitzer, M. Gibbon and J.B.W. Williams, Structured Clinical Interview for DSM-TV Axis I Disorders (SCID-I/P), (Version 2.0), Biometrics Research Department, New York State Psychiatric Institute, 722 West 168th Street, NY 10032, 1996.
11. M.B. First, R.L. Spitzer, M. Gibbon, J.B.W. Williams and L. Benjamin, Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II), (Version 2.0), Biometrics Research Department, New York State Psychiatric Institute, 722 West 168th Street, NY 10032, 1996.
12. K.N. Fountoulakis, A. Iacovides, P. Grammaticos, G. St. Kaprinis and P. Bech, Thyroid function in clinical subtypes of major depression: an exploratory study, BMC Psychiatry 4 (2004), 6.
13. M.F. Grunebaum, H.C. Galfalvy, M.A. Oquendo, A.K. Burke and J.J. Mann, Melancholia and the probability and lethality of suicide attempts, Br J Psychiatry 184 (2004), 534-535.
14. C. Mazure, J.C. Nelson and L.H. Rice, Reliability and Validity of the Symptoms of Major Depressive Illness, Arch Gen Psychiatry 43 (1986), 451-456.
15. E.D. Risby, J.K. Hsiao, T. Sunderland, H. Agren, M.V. Rudorfer and W.Z. Potter, The effects of antidepressants on the cerebrospinal fluid homovanillic acid:5-hydroxyindoleacetic acid ratio, Clin Pharmacol Ther 42 (1987), 547-554.
16. M.A. Rogers, M.A. Bellgrove, E. Chiu, C. Mileshkin and J.L. Bradshaw, Response selection deficits in melancholic but not nonmelancholic unipolar major depression, J Clin Exp Neuropsychol 26 (2004), 169-179.
17. D.N. Ruskin, D.A. Bergstrom, D. Baek, L.E. Freeman and J.R. Walters, Cocaine or selective block of dopamine transporters influences multisecond oscillations in firing rate in the globus pallidus, Neuropsychopharmacology 25 (2001), 28-40.
18. R.M. Salomon, J.S. Kennedy, B.W. Johnson Jr., D.E. Schmidt, J. Kwentus, H.E. Gwirtsman and M.H. Ebert, Association of a critical CSF tryptophan threshold level with depressive relapse, Neuropsychopharmacology 28 (2003), 956-960. Epub 2003 Mar 19.
19. R.M. Salomon, J.S. Kennedy, B.W. Johnson Jr., J.U. Blackford, D.E. Schmidt, J. Kwentus, H.E. Gwirtsman, J.F. Gouda and R.G. Shiavi, Treatment enhances ultradian rhythms of CSF monoamine metabolites in patients with major depressive episodes, Neuropsychopharmacology, Epub 2005, ahead of print April 27.
20. D.E. Schmidt, M.L. Roznoski and M.H. Ebert, Qualitative and quantitative HPLC analysis of monoamine neurotransmitters and metabolites in CSF and brain tissue using reductive electrochemical detection, Biomedical Chromotography 4 (1990), 215.
21. M.P. Szuba, A. Yager, B.H. Guze, E.M. Allen and L.R. Baxter Jr., Disruption of social circadian rhythms in major depression: a preliminary report, Psychiatry Res 42 (1992), 221-230.